Trial Profile
Correlation between bone mineral density response (BMD) to changes in iPTH and bone turnover markers (BTM) in patients on denosumab treatment: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 13 Jan 2017 New trial record